relevant disclosures attached
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Malar Hospitals Limited reported audited standalone profit after tax of Rs 361.17 lakhs for FY 2026 (standalone) and Rs 413.74 lakhs (consolidated), compared to Rs 4,126 lakhs in the previous year. The company has completely ceased business operations following the completion of a slump sale transaction to MGM Healthcare during FY 2024. Currently, the company has no active business and is essentially a cash shell holding approximately Rs 3,426 lakhs in cash and bank balances. The auditors (BSR & Co. LLP) issued an unmodified (clean) opinion but drew an Emphasis of Matter noting significant doubts about the company's future as it evaluates corporate restructuring options with no visibility of commencing new operations. Total income for standalone Q4 FY26 was Rs 65.63 lakhs, down from the previous year's figures that included business operations.
Shareholders face extreme uncertainty as the company is now a non-operating entity with no revenue-generating activities. The stock is essentially trading as a cash shell awaiting restructuring decisions, making it highly speculative. Pending litigation exposures (medico legal ~Rs 649.40 lakhs, GST appeals ~Rs 2,223 lakhs, VAT ~Rs 254.93 lakhs, IT ~Rs 198.83 lakhs) remain contingent liabilities that could impact the cash堆.